You are in:Home/Publications/Increased Serum Visfatin Levels in Patients with Type2 Diabetic Patients | |
Prof. Hesham Ali Mohamed Abdel-Halim Issa :: Publications: |
Title: | Increased Serum Visfatin Levels in Patients with Type2 Diabetic Patients |
Authors: | Osama S El-Shaer, Khaled M Belal, Hesham A Issa, Tawfik El-Adl |
Year: | 2012 |
Keywords: | Not Available |
Journal: | Not Available |
Volume: | Not Available |
Issue: | Not Available |
Pages: | Not Available |
Publisher: | Not Available |
Local/International: | International |
Paper Link: | Not Available |
Full paper | Not Available |
Supplementary materials | Not Available |
Abstract: |
Background: Obesity is highly associated with insulin resistance and the increased risk of type 2 diabetes and cardiovascular diseases. Visfatin is a cytokine that is highly expressed in visceral fat. It's expression in visceral fat is increased in obese subjects. Visfatin exerts insulin-mimetic effects and was as effective as insulin in reducing hyperglycemia in insulin-deficient diabetic mice. Objective: To study serum visfatin level in patients with type2 diabetes mellitus and to clarify its possible relationship with insulin |